IL-13 antibody (Interleukin 13) (AA 35-146)

Details for Product anti-IL13 Antibody No. ABIN4900267, Supplier: Log in to see
Antigen
  • IL13
  • IL-13
  • P600
  • Il-13
  • L13
  • interleukin 13
  • interleukin-13
  • IL13
  • Il13
  • IL-13
Alternatives
anti-Human IL-13 antibody for Enzyme Immunoassay
Epitope
AA 35-146
24
16
15
12
8
6
5
4
3
3
3
2
2
2
2
2
1
1
1
1
Reactivity
Human
247
81
53
10
9
5
3
2
1
1
1
Host
Mouse
160
129
70
5
3
Clonality (Clone)
Monoclonal ()
Conjugate
This IL-13 antibody is un-conjugated
39
14
13
8
8
7
7
6
6
5
5
5
4
4
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
Application
Cytometry by Time of Flight (CyTOF), Flow Cytometry (FACS), Neutralization (Neut), Western Blotting (WB)
206
204
103
54
42
28
23
13
12
12
11
10
7
5
4
4
4
3
3
2
2
1
1
1
1
1
1
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Immunogen E. coli-derived recombinant human IL-13, Gly35-Asn146, Accession # P35225
Clone 31606
Isotype IgG1
Specificity Detects human IL-13 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human IL-4 or recombinant mouse IL-13 is observed.
Purification Protein A or G purified from ascites
Sterility 0.2 μm filtered
Endotoxin Level <0.10 EU per 1 μg of the antibody by the LAL method.
Alternative Name IL-13 (IL13 Antibody Abstract)
Background Alternative Names: ALRHMGC116789, BHR1interleukin-13, IL13, IL-13MGC116788, interleukin 13, MGC116786, NC30, P600
Gene ID 3596
UniProt P35225
Research Area Cytokines, Innate Immunity, Cancer
Pathways JAK-STAT Signaling, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Proton Transport
Application Notes Western Blot 1 μg/mL
Flow Cytometry 2.5 μg/10^6 cells
Neutralization 1-4 μg/mL
CyTOF-ready
Restrictions For Research Use only
Reconstitution Reconstitute at 0.5 mg/mL in sterile PBS.
Buffer Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Preservative Without preservative
Storage 4 °C,-20 °C,-80 °C
Storage Comment Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt,-20°C to -70°C as supplied. 1 month,2°C to 8°C under sterile conditions after reconstitution. 6 months,-20°C to -70°C under sterile conditions after reconstitution.
Expiry Date 12 months
Supplier Images
Neutralization (Neut) image for anti-Interleukin 13 (IL13) (AA 35-146) antibody (ABIN4900267) Cell Proliferation Induced by IL-13 and Neutralization by Human IL-13 Antibody. Recom...
Flow Cytometry (FACS) image for anti-Interleukin 13 (IL13) (AA 35-146) antibody (ABIN4900267) Detection of IL-13 in Human PBMCs by Flow Cytometry. Human peripheral blood mononucle...
Neutralization (Neut) image for anti-Interleukin 13 (IL13) (AA 35-146) antibody (ABIN4900267) Cell Proliferation Induced by IL-13 and Neutralization by Human IL-13 Antibody. Recom...
Flow Cytometry (FACS) image for anti-Interleukin 13 (IL13) (AA 35-146) antibody (ABIN4900267) Detection of IL-13 in Human PBMCs by Flow Cytometry. Human peripheral blood mononucle...
Product cited in: van Meijgaarden, Haks, Caccamo, Dieli, Ottenhoff, Joosten et al.: "Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human ..." in: PLoS pathogens, Vol. 11, Issue 3, pp. e1004671, 2015 (PubMed). Method employed by authors: Blocking Peptide (BP) (Sample species: Human).

Haas, Amin, Ruth, Allen, Ahmed, Pakozdi, Woods, Shahrara, Koch: "In vivo inhibition of angiogenesis by interleukin-13 gene therapy in a rat model of rheumatoid arthritis." in: Arthritis and rheumatism, Vol. 56, Issue 8, pp. 2535-48, 2007 (PubMed). Method employed by authors: Neutralization (Neut) (Sample species: Rat (Rattus)).

Did you look for something else?